Gap finder
Search review questions
Each row is one question a systematic review asked: who, what, compared with what, and which outcome, with the effect it found and how certain that is. Words match anywhere in the field.
15,213 questions in 2,394 reviews
current versionsNo studies 15,213 · 100%Ungraded 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
GnRH‐a + estriol vs GnRH‐a ± placebo Quality of life · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + estriol vs GnRH‐a ± placebo Uterine Size · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + estriol vs GnRH‐a ± placebo Uterine bleeding · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + estriol vs GnRH‐a ± placebo Severity of vasomotor symptoms · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + estriol vs GnRH‐a ± placebo Rate of vasomotor symptoms · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + ipriflavone vs GnRH‐a ± placebo Quality of life · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + ipriflavone vs GnRH‐a ± placebo Uterine size · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + ipriflavone vs GnRH‐a ± placebo Uterine bleeding · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + ipriflavone vs GnRH‐a ± placebo Severity of vasomotor symptoms · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo Uterine bleeding · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
GnRH‐a + medroxyprogesterone acetate vs GnRH‐a ± placebo Severity of vasomotor symptoms · patients with uterine fibroids Add‐back therapy with GnRH analogues for uterine fibroids (2015) · Cochrane | no estimate extracted | NR | No studies |
Oral iron vs placebo (Comparison 3) Maternal mortality ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Oral iron vs placebo (Comparison 3) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Oral iron vs placebo (Comparison 3) Constipation ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous iron with oral iron vs oral iron (Comparison 6) Maternal mortality · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous iron with oral iron vs oral iron (Comparison 6) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous iron with oral iron vs oral iron (Comparison 6) Infections ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Erythropoietin (regardless of rout) with intravenous iron vs intravenous iron (Comparison 7) Maternal mortality · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Erythropoietin (regardless of rout) with intravenous iron vs intravenous iron (Comparison 7) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Erythropoietin (regardless of rout) with intravenous iron vs intravenous iron (Comparison 7) Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intravenous iron vs oral iron Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Erythropoietin (regardless of rout) with intravenous iron vs intravenous iron (Comparison 7) Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Maternal mortality ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Fatigue ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Persistent anaemia symptoms ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO 10,000 U of doses with intravenous iron vs intravenous iron (Comparison 8) Thromboembolic events ‐ not reported · patients with women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with oral iron vs oral iron (Comparison 10) Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Maternal mortality ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Fatigue ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Persistent anaemia symptoms ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Subcutaneous EPO with intravenous iron and oral iron vs intravenous iron with oral iron (Comparison 12) Thromboembolic events ‐ not reported · women with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Red blood cell transfusion vs non‐transfusion (Comparison 2) Maternal mortality ‐ not reported · patients with postpartum iron deficiency anaemia Treatment for women with postpartum iron deficiency anaemia (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Overall USN Shape cancellation, letter cancellation, and Bells' cancellation Lucas 2013 study · unilateral spatial neglect after stroke Pharmacological interventions for unilateral spatial neglect after stroke (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Disabilities Lucas 2013 study · unilateral spatial neglect after stroke Pharmacological interventions for unilateral spatial neglect after stroke (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Daily life functions Lucas 2013 study · unilateral spatial neglect after stroke Pharmacological interventions for unilateral spatial neglect after stroke (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Final height · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Near‐final height · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR All‐cause mortality · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Health‐related quality of life · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
Intervention NR Socioeconomic effects · male children and adolescents with short stature Aromatase inhibitors for short stature in male children and adolescents (2015) · Cochrane | no estimate extracted | NR | No studies |
COX‐2 NSAIDs vs placebo BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA) Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… (2015) · Cochrane | no estimate extracted | NR | No studies |
COX‐2 NSAIDs vs placebo Radiographic progression Mean change in mSASSS. Scale from 0 to 72 (higher is worse) · patients with axSpA (AS and nr‐axSpA) Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… (2015) · Cochrane | no estimate extracted | NR | No studies |
Traditional NSAIDs vs placebo BASMI Scale from 0 to 10 (higher is worse) · patients with axSpA (AS and nr‐axSpA) Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… (2015) · Cochrane | no estimate extracted | NR | No studies |
Traditional NSAIDs vs placebo Radiographic progression Mean change in mSASSS. Scale from 0 to 72 (higher is worse) · patients with axSpA (AS and nr‐axSpA) Non‐steroidal anti‐inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and… (2015) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic platelet transfusion at threshold of 10,000 vs higher transfusion threshold (20,000 or 30,000) Quality of life ‐ not reported · People with a haematological disorder Comparison of different platelet count thresholds to guide administration of prophylactic platelet… (2015) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic platelet transfusions with low‐dose schedule vs high‐dose schedule Quality of life ‐ not reported · People with a haematological disorder Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological… (2015) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic platelet transfusions with high‐dose schedule vs standard‐dose schedule Quality of life ‐ not reported · People with a haematological disorder Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological… (2015) · Cochrane | no estimate extracted | NR | No studies |
Prophylactic platelet transfusions with low‐dose schedule vs prophylactic platelet transfusions with standard‐dose schedule Quality of life ‐ not reported · People with a haematological disorder Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological… (2015) · Cochrane | no estimate extracted | NR | No studies |